INTRODUCTION AND OBJECTIVES: Vesicoureteral reflux (VUR) predisposes children to urinary tract infection (UTI) associated kidney damage. Clinicians currently lack a comprehensive diagnostic method to help identify children with VUR who are at high-risk for UTIs and pyelonephritis, which frequently results in overtreatment with prophylactic antibiotics or surgery. We profiled changes in urinary metabolome in children with VUR and a history of UTI compared with control urine to identify metabolic pathways related to increased risk from UTI in VUR patients.
INTRODUCTION AND OBJECTIVES: Vesicoureteral reflux (VUR) predisposes children to urinary tract infection (UTI) associated kidney damage. Clinicians currently lack a comprehensive diagnostic method to help identify children with VUR who are at high-risk for UTIs and pyelonephritis, which frequently results in overtreatment with prophylactic antibiotics or surgery. We profiled changes in urinary metabolome in children with VUR and a history of UTI compared with control urine to identify metabolic pathways related to increased risk from UTI in VUR patients.
METHODS: Urine was collected from VUR patients with history of single (n[41) and recurrent (n[44) UTIs, and age-matched pediatric controls (n[13). During sample collection patients had no active infection. Metabolome analysis was performed at Metabolon (Research Triangle Park, NC). Urine extracts were analyzed with 4 different liquid chromatography methods prior to mass spectrometry metabolome analysis. Reconstitution solvent for each sample contained a series of standards at fixed concentrations to ensure injection and chromatographic consistency. All samples were osmolality normalized prior to statistical analysis by ANOVA.
RESULTS: Abundance of 175 and 157 metabolites significantly differed between the urine of VUR patients diagnosed with single and recurrent UTIs and pediatric controls (P<0.05), respectively. Specifically, glycolysis and TCA-cycle intermediates were increased in single and recurrent UTI samples when compared with pediatric control samples, indicating increased energy production by the host cell or bacteria. In the children with UTI, we also found elevated metabolic products of amino acid degradation, particularly tryptophan catabolism suggestive of host inflammatory response and lymphocyte activation. Finally, we observed changes in bacterial metabolism metabolites from the glutamate degradation pathway and methyl-citrate cycle. Activation of these metabolic pathways after UTI resolution suggests ongoing bacterial metabolism or changes in bacterial species in patients with VUR.
CONCLUSIONS: We identified metabolomic changes indicative of host response and bacterial metabolism in the urine of patients with VUR and a history of UTIs. These changes will be further investigated as putative biomarkers to identify VUR patients at higher risk of UTIs.
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MP64-10 RETRACTABLE FORESKIN REDUCES URINARY TRACT INFECTIONS IN INFANT BOYS WITH VESICOURETERAL REFLUX
Joshua Chamberlin*, Dao Le, Vincent Delgado, Crystal Dorgalli, Kai-Wen Chuang, Heidi Stephany, Irene McAleer, Elias Wehbi, Antoine Khoury, Orange, CA INTRODUCTION AND OBJECTIVES: Circumcision reduces the risk of urinary tract infections (UTI) in boys younger than 1 year of age with vesicoureteral reflux (VUR). We sought to determine if fully retractable foreskin offers the same UTI risk reduction as circumcision. METHODS: We prospectively followed boys with primary VUR over a 2-year period. The degree of phimosis was graded on a scale of 0-5 at each visit. VUR grade, VUR laterality, and presenting indication for voiding cystourethrogram (VCUG) were obtained. Febrile UTIs were verified with pyuria and urine culture. A 2-year UTI-risk was calculated for circumcised and uncircumcised boys under 1 year of age with primary VUR based on phimosis grade over time.
RESULTS: Since June 2014 until June 2018, 84 boys, 14 circumcised and 70 uncircumcised, under the age of 1 year were diagnosed with primary VUR and followed prospectively for 2 years. No circumcised boy with VUR had a subsequent UTI (p<0.05). Boys with phimosis grades 4-5 had a 36.8% 2-year UTI risk, while boys with phimosis grade 3 had a 14.3% 2-year UTI risk. No UTIs were detected in the 22 boys with grade 0-2 phimosis (p<0.05).
CONCLUSIONS: Retractable foreskin reduces UTI risk in uncircumcised boys under 1 year of age with VUR, which is similar to the benefit seen with circumcision. Medical treatment of phimosis offers similar benefit to surgical treatment of phimosis in boys under 1 year of age with VUR. METHODS: An online 28-question survey was developed and administered via SurveyMonkeyä to anonymously query nonidentifying demographics, location (AUA section) and practice setting (academic vs. private) of Society of Pediatric Urology (SPU) members. Questions assessed impact of patient age and VUR grade in determining first-line surgical treatment recommendations. Six questions were used to stratify respondent impressions of robotic surgery on a favorability scale from 0 (least favorable) to 6 (most favorable). We also queried American Board of Urology (ABU) case logs for VUR treatment modalities from 2006e2016. Survey responses were analyzed with pertinent hypothesis testing, a twosided p-value <0.05 was considered statistically significant. RESULTS: 126 respondents completed the survey. Majority of respondents practice in academic settings (84, 66.7%) 
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